Many bacteria are resistant to killing ("tolerant") by typically bactericidal 21 antibiotics due to their ability to counteract drug-induced cell damage. Vibrio 22 cholerae, the cholera agent, displays an unusually high tolerance to diverse 23 inhibitors of cell wall synthesis. Exposure to these agents, which in other bacteria 24 leads to lysis and death, results in a breakdown of the cell wall and subsequent 25 sphere formation in V. cholerae. Spheres readily recover to rod-shaped cells 26 upon antibiotic removal, but the mechanisms mediating the recovery process are 27 not well-characterized. Here, we found that the mechanisms of recovery are 28 dependent on environmental conditions. Interestingly, on agarose pads, spheres 29 undergo characteristic stages during the restoration of rod shape. Drug inhibition 30
Introduction 44
The emergence of antibiotic resistance in bacterial pathogens requires the 45 development of new drugs and novel strategies to combat infection. However, 46 antibiotic resistance is not the sole explanation for antibiotic treatment failures. 47
Instead, some infections are caused by fully susceptible pathogens that are 48 thought to survive antibiotic treatment due to a high level of drug tolerance, i.e., 49 the capacity to stay alive in the presence of otherwise bactericidal drugs (1) (2) (3) (4) . 50
Dormant persister cells, which resist killing by all available antibiotics (4), 51
represent an extreme form of antibiotic tolerance. However, susceptible (non-52 persister) bacteria are sometimes capable of surviving severe antibiotic-imposed 53 damage, potentially providing an opportunity to acquire or evolve resistance 54 mechanisms. In addition, surviving bacteria typically exhibit a prolonged lag 55 phase after drug exposure (the post-antibiotic effect), during which they can 56 repair antibiotic induced damage. Currently our knowledge of the molecular 57 processes underlying antibiotic tolerance and the post-antibiotic effect is limited. 58
Understanding the mechanistic underpinnings of post-antibiotic recovery could 59 yield insights enabling the development of novel approaches to target tolerant 60 organisms. 61
We and others have previously shown that some Gram-negative bacteria, 62
including Burkholderia pseudomallei, Pseudomonas aeruginosa and Vibrio 63 cholerae, the causative agent of cholera, exhibit high tolerance to ordinarily 64 bactericidal cell wall acting antibiotics (e.g. beta lactams) (5-7). In V. cholerae, for 65 example, exposure to beta lactam antibiotics at multiples of the minimum 66 inhibitory concentration (MIC) results in cell wall loss, similar to well-studied 67 model organisms, such as E. coli (5) . However, in contrast to E. coli, V. cholerae 68 survives as wall-deficient spheres, similar to L-forms (8), with the notable 69 difference that V. cholerae spheres do not divide while in this wall-less state. 70
Remarkably, however, the wall-deficient spherical cells remain viable and have 71 minimal plating defects on media lacking antibiotics (5). Sphere survival in vivo 72 (in the mouse intestine) and in vitro is enabled by the two-component cell wall 73
stress response system wigKR (aka vxrAB), which controls several processes 74 including cell wall (peptidoglycan, PG) biosynthesis, motility, type VI secretion 75 and biofilm formation (9) (10) (11) . 76
The many steps in PG synthesis include cytoplasmic production of the 77 lipid II precursor, translocation of this precursor into the periplasm, and finally 78 precursor incorporation into the cell wall sacculus via polymerization 79 (transglycosylation, TG) and intercrosslinking (transpeptidation, TP) reactions. 80 TG and TP reactions are mediated by two spatiotemporally distinct entities, the 81
Rod system (with RodA as the polymerase and a class B Penicillin Binding 82
Protein [bPBP] as the crosslinking enzyme) and the class A PBPs (aPBPs) that 83 can catalyze both TG and TP reactions (12) . In addition, aPBPs require outer-84 membrane localized lipoproteins (Lpos) for their activity (13, 14) and the Rod 85 system is associated with (and requires for its activity) the cytoskeletal actin 86 homolog MreB (15) (16) (17) (18) . Almost the entire V. cholerae PG synthesis pathway is 87 upregulated through wigKR/vxrAB in response to antibiotics that disrupt cell wall 88 synthesis (9), with the notable exception of components of the Rod system. 89
We have little knowledge of how V. cholerae cell envelope biogenesis 90 pathways enable recovery from the antibiotic-induced spherical state and if 91 additional factors contribute to survival and recovery from this state. Here, we 92 have characterized the post-antibiotic recovery process in V. cholerae. 93
Microscopy using fluorescent protein fusions and cell wall stains revealed that 94 during an ordered sphere recovery process, aPBP1a localizes prominently to the 95 outgrowth area and its function appears to account for the majority of the initial 96 deposition of new cell wall material. In contrast, the Rod system, which is 97 ultimately required for sphere recovery, plays a minor role in the initial recovery 98 stages. We also used transposon insertion sequencing (TnSeq) to identify the 99 genetic requirements for V. cholerae tolerance to penicillin and found that there is 100 an enrichment in genes important for cell wall and outer membrane biogenesis 101 functions among mutations that confer post-antibiotic fitness defects. Collectively, 102 our findings reveal the pleiotropic nature of beta lactam tolerance, provide 103 potential targets for beta lactam adjuvants, and have implications for the role of 104 aPBPs in de novo PG template generation. 105
106

Results
107
Distinct mechanisms of recovery in different growth conditions 108
In previous work, we used microscopy to characterize V. cholerae sphere 109 formation following exposure to antibiotics that interfere with cell wall synthesis 110 (5). Here we used a similar approach to investigate how spheres revert to rod 111 shape. As observed previously, V. cholerae cells grown in minimal medium 112 exposed to penicillin G form non-dividing spheres exhibiting well-defined 113 demarcations between the phase-dark cytoplasm, an enlarged periplasmic space 114 visible as a phase-light bubble, and a clearly visible outer membrane ( Fig. 1A) . 115
Timelapse light microscopy was used to monitor cell morphology on agarose 116 pads after removal of the antibiotic by washing. In these conditions, 117 approximately 10 to 50% of cells fully recovered to form microcolonies (see 118
Movie S1 for an example). While these conditions were not as favorable for 119 recovery as plating on LB agar (5), they enabled us to discern steps in sphere 120 recovery, which appeared to take place in partially overlapping stages in wild 121 type (wt) cells ( Fig. 1B) . Initially, phase dark material engulfed the periplasmic 122 space (engulfment stage); then, the now elliptical-shaped cells reduced their 123 widths (constriction phase) followed by elongation (elongation phase); finally 124 these elongated cell masses gave rise to rod-shaped cells, which proliferated into 125 a microcolony. 126
The pattern of recovery of rod shape described above is distinct from that 127 described for osmostabilized, beta lactam treated E. coli cells (19); however the 128 latter experiments were conducted in microfluidic chambers rather than agarose 129 pads. Unlike E. coli, V. cholerae does not require osmostabilization for sphere 130 formation; furthermore, V. cholerae spheres retain viability and structural integrity 131 in LB and minimal medium, as well as in rabbit cecal fluid (5). Unlike the 132 conditions in microfluidic chambers, agarose pads may provide external 133 structural support to recovering spheres. Consistent with this idea, we found that 134 the pattern and dynamics of recovery were very different when we repeated 135 recovery experiments in liquid M9 minimal medium. Following exposure to penG 136 and washing, cells were intermittently removed from the liquid medium and 137 imaged. We did not observe the distinct stages of recovery observed on agarose 138 pads; in general, sphere morphology did not change for the duration of the 139 experiment (12 h), except for a slight increase in volume ( Fig. 2) . However, 140 normal, rod-shaped cells appeared after ~ 4-5 hours of post-antibiotic incubation 141 ( Fig. 2 , yellow arrow). We surveyed ~ 100 cells per time point in each of two 142
biological replicate experiments and did not find any intermediates, suggesting 143 that if such intermediates form, they do so at a frequency <1/100. The origin of 144 the rod-shaped cells is not clear, but they may have directly budded off of 145 spheres from a newly-formed pole juxtaposed to the periplasm, similar to the 146 recovery protrusions observed in E. coli after treatment with beta lactams (19) or 147 lysozyme (20). Indeed, we observed some rods that appeared to be budding off 148 of spheres ( Fig. 2, red elongation complex (Rod system) and the aPBPs (15, 21, 22) . Nearly the entire 156 cell wall synthesis pathway, including aPBPs, is upregulated by the wigKR cell 157 wall stress response two component system. Members of the Rod system, 158 however, are conspicuously absent from the wigKR regulon (9). We thus 159 hypothesized that aPBPs were crucial determinants of post-antibiotic recovery. 160
To investigate the role of PBP1a, V. cholerae's primary aPBP (23) in the 161 recovery process, we created a functional ( Fig. S1 ) PBP1amCherry translational 162 fluorescent protein and tracked its localization in recovering spheres on agarose 163 pads. In the first stages of recovery, PBP1amCherry was diffuse, but then it 164 assumed a striking, band-like pattern along the leading edge of the periplasmic 165 engulfment, migrating ahead of the phase-dark cytoplasmic material ( Fig. 3,  166 yellow arrow). Inhibiting PBP1a's TG activity using moenomycin (10 µg ml -1 , 10x 167 MIC), arrested sphere recovery in the pre-engulfment stage and prevented 168
proper PBP1a localization, suggesting that the recovery process depends on 169
PBP1a's PG synthesis capabilities (or at least transglycosylation function). We 170 also tested whether MreB was necessary for PBP1a's leading edge localization 171 by treating the recovering PBP1amcherry strain with the MreB inhibitor MP265 172 (24) (200 µM, 10 x MIC). Inhibition of MreB suppressed recovery and completion 173 of periplasmic engulfment, establishing that MreB is important for sphere to rod 174 recovery as shown before for E. coli (19). However, engulfment was only partially 175 defective in spheres treated with MP265 and PBP1a still localized in a 176 concentrated, band-like pattern in the presence of MP265 ( Fig. 3, green arrow) . 177
Thus, while both MreB and PBP1a are important for recovery, aPBPs seems to 178 function earlier than the Rod system in the process. Since PBP1a was concentrated around the leading edge during the engulfment 183 process, we hypothesized that the aPBPs might be required for the 184 commencement of cell wall synthesis after antibiotic-induced murein degradation. 185
To test this, we treated cells with PenG, removed the antibiotic by washing, and 186 then used the fluorescent D-amino acid HADA to visualize insertion of new cell 187 wall material. An ∆ldtA ∆ldtB mutant defective in L,D transpeptidase activity (25) 188 was used in these experiments to exclude PG synthesis-independent HADA 189 incorporation. In untreated spheres, cell wall deposition generally started at the 190 opposite side of the periplasm (Fig. 4) . This is likely the place where aPBPs and 191 their OM activators interact first, as the inner and outer membranes are in close 192 proximity in this area. In the presence of the MreB inhibitor MP265 (at 10 x MIC), 193 initial cell wall deposition was reduced compared to untreated spheres, but 194 remained detectable. In contrast, when cells were incubated with moenomycin 195
(10 x MIC), incorporation of HADA-labeled material was drastically reduced (Fig. 196 4, see Fig. S2 for image adjusted to lower dynamic range). It follows that while 197 both the aPBPs and MreB are required for sphere recovery, the aPBPs are more 198 active than the Rod system in producing nascent PG in recovering spheres. 199
200
Identification of genes required for post-antibiotic recovery 201
We used transposon insertion site sequencing (TIS, aka TnSeq) to identify 202 factors required for sphere recovery. Since we observed differences in recovery 203 dynamics on solid (agarose pad) versus in liquid media, we combined both 204 conditions in TIS experiments to uncover a broad array of recovery factors. Cells 205 were exposed to PenG in liquid culture for 4 hr, washed, outgrown overnight in 206 the absence of antibiotics, and then plated. The insertion sites in the Tn library 207
were sequenced before addition of the antibiotic (PRE), after incubation in PenG 208 (POST), and after the overnight outgrowth followed by plating (OG). Strikingly, 209
comparison of the insertion profiles in the PRE and POST conditions ( Fig. 5A ) 210 did not reveal any genes that met stringent criteria for differential fitness ( >10-211 fold difference in insertion abundance, p-val <0.01). Thus, no single mutation 212 appears to lead to catastrophic lysis in V. cholerae treated with penicillin G. In 213 contrast, comparing the insertion profiles in the POST vs OG conditions revealed 214 55 genes which had reduced fitness during post-antibiotic outgrowth (>10-fold 215 fewer insertions along with p-val <0.01). 216
Notably, there was an enrichment of several functional pathways among 217 the 55 genes required for robust post-antibiotic outgrowth ( Fig. 5B) . Included 218 among the enriched categories were genes predicted to be required for cell wall 219 synthesis and recycling (pbp1A, vc2153, ampG, pbp5, lpoB, mltA) , 220
lipopolysaccharide (LPS) biosynthesis (core biosynthesis, Lipid A acylation and 221
O-antigen synthesis pathways, vc0212, vc0223, vc0225, vc0236, vc0237, 222 vc0240) , intrinsic stress resistance (superoxide dismutase, rpoE), phosphate 223 uptake (vc0724-0726) and chromosome dynamics (mukBEF) (Fig. S3) . 224
Intriguingly, some of the hits (vc2153, rpoE, PG synthesis factors) were 225 homologs or analogs of factors identified in a recent TnSeq screen for genes that 226 promote tolerance to beta lactams in Burkholderia pseudomallei and B. 227 thailandensis (6), raising the possibility that there are shared tolerance 228 requirements across Gram-negative bacteria. 229
We were particularly interested in the contribution of cell envelope 230 functions to sphere recovery and therefore prioritized genes involved in LPS and 231 cell wall metabolism for further studies. We first focused on the 6 LPS 232 biosynthesis genes that answered our screen. To validate the requirement of 233 LPS core biosynthesis in the recovery process, we created an insertion mutant in 234 vc0225, the gene encoding heptosyltransferase I. This mutation is expected to 235 result in a truncated LPS molecule lacking an outer core and O-antigen and 236 consistent with this, the mutant strain did not have detectable high molecular 237
weight LPS in isolated outer membrane (OM) material ( Fig. S4) . Wild type (wt) 238 and vc0225::kan mutant cells were compared in time-dependent viability 239 experiments. Exposing wt cells to penicillin G (at 10 x MIC) in minimal medium 240 (unlike LB) in some experiments permitted initial growth ( Fig. 6A) . We do not 241 know the reason for this initial growth (V. cholerae does not become resistant to 242 PenG in M9, as evidenced by sphere formation (Fig. 6B) , but it is possible that 243 antibiotic diffusion through the OM is slower in minimal than in rich medium. 244
Disruption of the LPS core gene vc0225 resulted in the absence of initial growth 245 and a subsequent 100-fold plating defect after exposure to PenG (Fig. 6A) , 246
corroborating the TnSeq result. This survival defect could be complemented by 247 expressing vc0225 from a neutral chromosomal locus. Light microscopy revealed 248 that the vc0225 mutant strain still formed spheres (Fig. 6B) ; however, these 249 spheres were morphologically distinct from wt spheres. In contrast to wt 250 spheres, which were usually seen as single cells, exhibiting well-demarcated 251 separation between the phase dark cytoplasm and the phase light periplasm 252 ( Fig. 1A) , vc0225 mutant cells were mostly grape-like masses showing a 253 checkered pattern of distinct periplasmic enclaves in a sometimes divided 254 cytoplasm ( Fig. 6B) . Visualizing an inner membrane marker (PBP1amCherry) 255 also revealed the lack of a clear distinction between the inner and outer 256 membrane in the mutant. Upon removal of the antibiotic, vc0225 spheres were 257 defective in all stages of the recovery process; the spheres underwent modest 258 enlargement without initiating periplasmic engulfment (Fig. 6C) . Thus, intact LPS 259 appears necessary for sphere anatomy and internal organization; moreover, 260 these LPS-associated sphere defects seem to impair sphere recovery. 261 262
Sphere integrity does not depend on Lipid A modifications 263
The outer membrane appears to be the principle load-bearing structure in beta 264 lactam-induced spheres, because these cells are largely devoid of detectable cell 265 wall material and are more susceptible to detergents and antimicrobial peptides 266 (5, 7). V. cholerae LPS contains at least two modifications which are not found in 267 E. coli LPS and that could potentially stabilize V. cholerae spheres. These 268 modifications, addition of phosphoethanolamine to the 1-phosphate group of lipid 269
A and an unusual glycine addition to a hydroxylauryl chain at the 2' position of 270 Lipid A, both promote resistance to polymyxin (26, 27); glycinylation (by the alm 271 system) is dominant, but the pH-dependent EptA can promote residual polymyxin 272 resistance when the alm system is inactivated (22) . We investigated whether 273 these modifications were required for sphere formation and integrity by deleting 274 the alm operon, which encodes the glycine transferase activity, and eptA, which 275 encodes the ethanolamine transferase. As expected, the alm mutation abrogated 276 polymyxin resistance on LB (Fig. S5) . When these mutants, either alone (not 277 shown) or in combination, were exposed to PenG they formed spheres that were 278 indistinguishable from wt spheres ( Fig. 7A) , indicating that these Lipid A 279 modifications are not required for sphere generation. The ∆alm ∆eptA mutations 280
were then combined with disruptions in vc0225 or vc0212 (encoding the 3-281 hydroxy laurate transferase LpxN (28)) to test the effect of a core mutation 282 after PenG exposure ( Fig. 7A ) but these spheres had ~5-fold decrease in 287 viability compared to the wt (Fig. 7B) . The ∆alm ∆eptA vc0225::kan mutant also 288 formed spheres, but resulted in a more dramatic reduction in viability compared 289 to the ∆alm∆eptA vc0212::kan mutant ( Fig. 7B) and to the single vc0225::kan 290 mutant , where there was less pronounced loss of viability after 3 h (compare 291 with Fig. 6A ). Thus, LPS core and O-antigen appear to be more critical for 292 sphere formation/integrity and viability than Lipid A modifications. However, 293 glycinylation and/or ethanolamine addition to Lipid A appear to promote 294 maintenance of sphere integrity in the absence of LPS core and O-antigen, 295
suggesting that these modifications contribute to OM stability in this context. 296
297
The sigma E cell envelope stress response is required for penicillin 298 tolerance 299
The TnSeq analysis implicated several genes in the sigma E cell 300 envelope stress response as important for sphere viability/recovery (Fig. S3) . 301
Misfolding of outer membrane proteins such as OmpU triggers the V. cholerae 302 envelope stress response, wherein sigma E directs the transcription of a set of 303 genes involved in variety of cell envelope maintenance functions (29, 30) . We 304 found that the abundance of RpoE markedly increased several hours after cells 305 were exposed to diverse antibiotics that interrupt cell wall synthesis (PenG, 306 phosphomycin or D-cycloserine), consistent with the idea that this sigma factor 307 promotes sphere survival (Fig. 8A) . Interestingly, PenG treatment increased 308
RpoE abundance independent of OmpU (Fig. 8B) . The importance of sigma E 309 for survival after PenG exposure was established by measuring time-dependent 310 viability after antibiotic challenge. Since rpoE is essential, we used an 311 ∆rpoE∆ompU strain (the latter deletion enables rpoE deletion (30)), to investigate 312 rpoE's importance for sphere viability/recovery. Following exposure to PenG, the 313 ∆rpoE∆ompU strain exhibited a drastic (~1000-fold) plating defect compared to 314 the wild type and ∆ompU controls (Fig. 8B) . Thus, sigma E (and presumably the 315 regulon it controls) is a crucial determinant of V. cholerae beta lactam tolerance. 316
The importance of the sigma E response for beta lactam tolerance 317 indicated the strong possibility that PenG-treated V. cholerae sustain OM 318 damage; this in turn suggested that beta lactam exposure might sensitize cells to 319 high molecular weight (HMW) antibiotics that are typically too large to permeate 320 the Gram-negative cell envelope; e.g. vancomycin and ramoplanin. To test this, 321
we plated cells exposed to PenG or a vehicle control on either LB or plates 322 containing vancomycin (100 µg ml -1 ) or ramoplanin (100 µg ml -1 and 500 µg ml -1 ) 323 ( Fig. 8C) . While untreated cultures plated at close to 100% on any of these 324 plates, pre-treatment with PenG for 3h resulted in a 10-to 50-fold plating defect 325 on either HMW antibiotic. Thus, while V. cholerae is tolerant to beta lactam 326 antibiotics, these agents appear to sensitize it against HMW antibiotics. 327 328
Discussion
329
Antibiotic tolerance, the ability to survive and fully recover from exposure to 330 normally lethal doses of bactericidal antibiotics, is a common cause of treatment 331 failure and serves as a stepping-stone for the development of antibiotic 332 resistance (31). The mechanism(s) of antibiotic tolerance and a related 333 phenomenon, the post-antibiotic effect (the recovery process of tolerant cells) are 334 understudied and insufficiently understood. 335
Here, we investigated the post-antibiotic effect in V. cholerae, an organism 336 highly tolerant to typically bactericidal inhibitors of cell wall synthesis. Following 337 beta lactam treatment, this pathogen forms viable cell wall deficient spheres that 338
can re-establish their characteristic rod morphology when antibiotics are no 339 longer present. We found that the process of restoration of rod shape appears to 340 be media dependent and to differ from that described for the recovery of E. coli 341 spheres induced by cefsulodin (19) . At least on agarose pads, 3 successive 342 steps characterized the recovery process. Recovery involves re-localization of 343
PBP1a to the leading edge of a periplasmic engulfment process and aPBPs, 344 rather than the Rod system, have a primary role, particularly in the early steps of 345 recovery. The characteristic steps and protein localization patterns involved in 346 restoration of rod shape suggests that V. cholerae's ability to recover from a well-347 less spherical state may be a previously unappreciated type of programmed 348 response to stress. Furthermore, the capacity of wall-less spheres to remain 349 viable and to regain rod shape in a step-wise fashion is not restricted to V. 350 cholerae, but found in several other Gram-negative organisms (7, 20, 32) . 351
Not surprisingly, TnSeq analysis revealed that genes required for 352 peptidoglycan biogenesis were essential for sphere recovery; however, additional phenotypes that cannot easily be explained by cell wall precursor depletion 373 alone. The absence of the clear demarcation between the inner and outer 374 membrane in the LPS core (vc0225 mutant) deficient spheres suggests that IM 375 material (IM phospholipids and associated proteins) may be present in the OM. 376
More broadly, our findings demonstrate the importance of LPS integrity for V. 377 cholerae survival of cell wall damage; it is likely that LPS structure/strength 378 modulates susceptibility to beta lactams in other bacteria as well, as has been 379 suggested in E. coli (35) . 380
As expected, we also found cell wall synthesis and recycling factors to be 381 required for sphere recovery. The prominent role of PBP1a, rather than its 382 paralog PBP1b, in the recovery process supports our previous data showing that 383
PBP1a is the principle aPBP in V. cholerae (23, 36) and is consistent with 384 observations in lysozyme-treated, spherical E. coli, where that organism's 385 principal aPBP (PBP1B) is required for recovery (32). Intriguingly, PBP1a 386 localized as a concentrated ring around the outgrowth area. Moenomycin, an 387 aPBP TG inhibitor, abrogated PBP1a's capacity to localize to the outgrowth area 388 as well as sphere recovery, revealing the essentiality of aPBP enzymatic activity 389 for the recovery process. In contrast, MreB, and by extension likely the 390 associated Rod system appeared to play a minor role during the early stages of 391 recovery (though MreB was ultimately necessary for full sphere-to-rod 392 conversion). We do not know the exact structure of possible remnant PG in 393 spheres; however, our results suggest that aPBPs are more efficient than the 394
Rod system at starting PG synthesis in the absence of a rod-shaped scaffold. 395
Recent data suggest that MreB determines the directionality of Rod-mediated PG 396 synthesis through its axial, membrane-curvature-induced orientation in the cell 397 (37). Our data are in line with such a model, as axial localization cues are lost in 398 a sphere. Thus, the Rod system might rely on the aPBPs to first mediate some 399 degree of sphere constriction, inducing heterogeneity in membrane curvature 400 that would then enable ordered, Rod-mediated PG deposition resulting in cell 401
elongation. 402
In summary, we provide here an analysis of factors required for post-403 antibiotic recovery in V. cholerae treated with a beta lactam antibiotic. Our results 404 directly demonstrate a role for OM integrity in beta lactam tolerance and establish 405 a differential role for aPBPs and the Rod system for post-antibiotic recovery. The 
Molecular techniques/strain construction 431
For molecular cloning purposes, PCR was conducted using Q5 high fidelity 432 polymerase (NEB). For diagnostic PCRs, OneTaq mastermix (NEB) was used 433 instead. All cloned constructs were verified using sequencing. All plasmid cloning 434 was done using Isothermal Assembly (ITA) (38). Oligos are summarized in Table  435 S1 and strains in Table S2 . Unless otherwise noted, all strains were constructed 436 in the El Tor N16961 background. 437
Unless otherwise noted, mutants were constructed as previously 438 described using the suicide plasmid pCVD442 (39) and homologous 439 recombination to replace genes with the sequence 440 TAATGCGGCCGCACTCGAGTAATAATGATGA. Briefly, the E. coli donor strain 441
Sm10 carrying a pCVD-based deletion plasmid was mixed 1:1 with the V. 442 cholerae recipient on an LB plate and incubated for at least 2h at 37 ˚C. The cell 443 mixture was then streaked out on a plate containing carbenicillin (100 µg/ml) and 444 streptomycin (200 µg/ml) to select against the donor strain and for recipients that 445 have integrated the deletion plasmid. To counterselect against pCVD, a single 446 colony was then streaked out on sucrose agar (15 g/L agar, 10 g/L tryptone, 5 447 g/L yeast extract, filter-sterilized sucrose added after autoclaving to 10 % final 448 concentration) + streptomycin. Plates were incubated at ambient temperature for 449 1 day and then transferred to 30 ˚C, followed by additional incubation for 1 or 2 450 days. Successful mutants were verified via colony PCR using primers flanking 451 the gene of interest. 452
For the vc0225 disruption, sacB-based counterselection did not work due to the 453 inability of LPS core mutants to grow on sucrose agar. We therefore used a kanR 454 TnSeq was conducted as described before (42) (43) (44) ; briefly, cultures were 477 subjected to transposon (mariner) mutagenesis in duplicate. In the resulting 478 libraries (~200,000 colonies/replicate), whle population transposon-chromosome 479 junctions were sequenced (PRE sample, see below); the libraries were then 480 frozen down in 30 % glycerol (-80˚C). For the experiment, libraries were grown to 481 an OD600 ~0.5 then exposed to penicillin G (100 µg/ml, 10 x MIC) for 4 h and 482 sequenced again (POST sample), followed by washing to remove the antibiotic 483 and outgrowth overnight; after which the libraries were sequenced again 484 (outgrowth, OG sample). Sequencing was performed as follows. Pelleted 485 libraries were lysed and DNA fragmented using NEB fragmentase, followed by 486 blunting (Blunting enzyme mix, NEB), A-tailing and ligation of specific adaptors. 487
Transposon-DNA junctions were then PCR amplified using transposon-and 488 adaptor-specific primers. The libraries were then sequenced on an Illumina 489
MiSeq. Data analysis was essentially conducted as described (42-44), however, 490
to avoid false negatives that did not pass our stringent cut-off, we also used a 491 candidate-based approach (based on known genetic interactions between cell 492 envelope functions) to visually inspect the TnSeq dataset in the genome browser 493
Artemis (this approach yielded e.g. WigKR and RpoE). 494 495
Recovery on agarose pads 496
For recovery timelapses, overnight cultures were diluted 100-fold into fresh M9 497 added, followed by incubation for another 3h. Cells were then washed twice in 499 antibiotic-free medium and applied to agarose patches (0.8 % agarose in M9) 500 and imaged every 5 min on a Leica DMi8 inverted microscope with incubated (30 501 ˚C) stage. For fluorescent readings, exposure time was 500 ms (mCherry), 300 502 ms (msfGFP) or 1000 ms (HADA). 503 504
Recovery in liquid medium 505
Overnight cultures were diluted 100fold into fresh M9 MM, then grown until 506 OD600 = 0.3 (3.5 h) at 37 ˚C shaking. Antibiotic was then added, followed by 507 incubation for another 3h. Cells were then washed twice in antibiotic-free medium 508 and diluted 10fold into same containing 100 µM HADA. Cells were withdrawn at 509 the indicated time points, washed once with M9 and imaged as detailed above. 510 511 512 primarily mediated by aPBPs. N16961 ∆ldtA ∆ldtB cells were exposed to PenG 536 (100 µg ml -1 , 10 x MIC) in M9 minimal medium for 3 h (T0 and T3), followed by 537 washing and resuspension in fresh, pre-warmed M9 containing the fluorescent D-538 amino acid analog HADA as a cell wall label (4-12 h). Scale bar = 5 µm. The 539
Figure legends
MreB inhibitor MP265 was added at 200 µM (10 x MIC) and the aPBP inhibitor 540 moenomycin at 10 µg ml -1 (10x MIC). Pretreatment with PenG sensitizes cells to high molecular weight antibiotics. 577 Cells were exposed to either vehicle (no pretreatment) or Penicillin G (PenG, 100 578 µg ml -1 ) for 3h, followed by plating on either LB, vancomycin (vanco, 200 µg ml -1 ), 579 or ramoplanin (ramo, 100 µg ml -1 or 500 µg ml -1 ). 580 
